BICARA THERAPEUTICS INC. COMMON STOCK

NASDAQ: BCAX (Bicara Therapeutics Inc.)

Last update: 24 Jan, 1:12AM

11.97

0.05 (0.42%)

Previous Close 11.92
Open 11.86
Volume 272,719
Avg. Volume (3M) 421,954
Market Cap 651,354,752
Price / Book 1.30
52 Weeks Range
11.51 (-3%) — 28.09 (134%)
Earnings Date 12 Nov 2024
Diluted EPS (TTM) -1.09
Total Debt/Equity (MRQ) 0.09%
Current Ratio (MRQ) 36.01
Operating Cash Flow (TTM) -52.76 M

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Mixed
Biotechnology (Global) Mixed Mixed
Stock Bicara Therapeutics Inc. Bearish -

AIStockmoo Score

1.6
Analyst Consensus 3.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 5.0
Technical Oscillators -2.0
Average 1.63

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BCAX 651 M - - 1.30
ASND 8 B - - -
LEGN 6 B - - 5.17
MTSR 3 B - - -
NAMS 2 B - - 5.39
PROK 2 B - - 91.32

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 6.26%
% Held by Institutions 69.97%
52 Weeks Range
11.51 (-3%) — 28.09 (134%)
Price Target Range
31.00 (158%) — 45.00 (275%)
High 45.00 (HC Wainwright & Co., 275.94%) Buy
Median 38.00 (217.46%)
Low 31.00 (Wedbush, 158.98%) Buy
Average 38.00 (217.46%)
Total 2 Buy
Avg. Price @ Call 11.89
Firm Date Target Price Call Price @ Call
Wedbush 12 Feb 2025 31.00 (158.98%) Buy 12.13
06 Feb 2025 31.00 (158.98%) Buy 12.60
HC Wainwright & Co. 27 Jan 2025 45.00 (275.94%) Buy 11.65
06 Dec 2024 42.00 (250.88%) Buy 21.10

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria